Blood Vessel Regeneration using Human Umbilical Cord-derived Endothelial Progenitor Cells in Cyclophosphamide-treated Immune-deficient Mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Endothelial cells are a vital constituent of most mammalian organs and are required to maintain the integrity of these tissues. These cells also play a major role in angiogenesis,inflammatory reactions, and in the regulation of thrombosis. Angiogenesis facilitates pulp formation and produces the vessels which are essential for the maintenance of tooth homeostasis. These vessels can also be used in bone and tissue regeneration, and in surgical procedures to place implants or to remove cancerous tissue. Furthermore, endothelial cell regeneration is the most critical component of the tooth generation process. The aim of the present study was to stimulate endothelial regeneration at a site of acute cyclophosphamide (CP)-induced endothelial injury by treatment with human umbilical cord-derived endothelial/mesenchymal stem cells (hEPCs). We randomly assigned 16 to 20-week-old female NOD/SCID mice into three separate groups, a hEPC (1 ×10^5cells) transplanted, 300mg/kg CP treated and saline (control) group. The mice were sacrificed on days 5 and 10and blood was collected via the abdominal aorta for analysis. The alanine transaminase (ALT), aspartate aminotransferase (AST), serum alkaline phosphatase (s-ALP), and albumin (ALB) levels were then evaluated. Tissue sections from the livers and kidneys were stained with hematoxylin and eosin (HE) for microscopic analysis and were subjected to immunohistochemistry to evaluate any changes in the endothelial layer. CP treatment caused a weight reduction after one day. The kidney/body weight ratio increased in the hEPC treated animals compared with the CP only group at 10 days. Moreover,hEPC treatment resulted in reduced s-ALP, AST, ALT levels compared with the CP only group at 10 days. The CP only animals further showed endothelial injuries at five days which were recovered by hEPC treatment at 10 days. The number of CD31-positive cells was increased by hEPC treatment at both 5 and 10 days. In conclusion, the CP-induced disruption of endothelial cells is recovered by hEPC treatment,indicating that hEPC transplantation has potential benefits in the treatment of endothelial damage.
Abstract
Endothelial cells are a vital constituent of most mammalian organs and are required to maintain the integrity of these tissues. These cells also play a major role in angiogenesis,inflammatory reactions, and in the regulation of thrombosis. Angiogenesis facilitates pulp formation and produces the vessels which are essential for the maintenance of tooth homeostasis. These vessels can also be used in bone and tissue regeneration, and in surgical procedures to place implants or to remove cancerous tissue. Furthermore, endothelial cell regeneration is the most critical component of the tooth generation process. The aim of the present study was to stimulate endothelial regeneration at a site of acute cyclophosphamide (CP)-induced endothelial injury by treatment with human umbilical cord-derived endothelial/mesenchymal stem cells (hEPCs). We randomly assigned 16 to 20-week-old female NOD/SCID mice into three separate groups, a hEPC (1 ×10^5cells) transplanted, 300mg/kg CP treated and saline (control) group. The mice were sacrificed on days 5 and 10and blood was collected via the abdominal aorta for analysis. The alanine transaminase (ALT), aspartate aminotransferase (AST), serum alkaline phosphatase (s-ALP), and albumin (ALB) levels were then evaluated. Tissue sections from the livers and kidneys were stained with hematoxylin and eosin (HE) for microscopic analysis and were subjected to immunohistochemistry to evaluate any changes in the endothelial layer. CP treatment caused a weight reduction after one day. The kidney/body weight ratio increased in the hEPC treated animals compared with the CP only group at 10 days. Moreover,hEPC treatment resulted in reduced s-ALP, AST, ALT levels compared with the CP only group at 10 days. The CP only animals further showed endothelial injuries at five days which were recovered by hEPC treatment at 10 days. The number of CD31-positive cells was increased by hEPC treatment at both 5 and 10 days. In conclusion, the CP-induced disruption of endothelial cells is recovered by hEPC treatment,indicating that hEPC transplantation has potential benefits in the treatment of endothelial damage.
참고문헌 (23)
- Anton E, "Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice", Tissue Cell, 29, pp.1~9 (1997)
- Celletti FL, "Vascular endothelial growth factor enhances atherosclerotic plaque progression", Nat Med, 7, pp.425~429 (2001)
- Chai Y, "Prospects for tooth regeneration in the 21st century: a perspective", Microsc Res Tech, 60, pp.469~479 (2003)
- Gronthos S, "Stem cell properties of human dental pulp stem cells", J Dent Res, 81, pp.531~535 (2002)
- Hacking SA, "Applications of microscale technologies for regenerative dentistry", J Dent Res, 88, pp.409~421 (2009)
- Kalka C, "Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization", Proc Natl Acad Sci U S A, 97, pp.3422~3427 (2000)
- Kaushal S, "Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo", Nat Med, 7, pp.1035~1040 (2001)
- Levenberg S, "Engineering blood vessels from stem cells: recent advances and applications", Curr Opin Biotechnol, 16, pp.516~523 (2005)
- Lyden D, "Impaired recuritemnt of bonemarrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth", Nat Med, 7, pp.1194~1201 (2001)
- Meijer GJ, "Cellbased bone tissue engineering", PLoS Med, 4, pp.e9~ (2007)
- Moulton KS, "Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice", Circulation, 99, pp.1726~1732 (1999)
- Ohazama A, "Stem-cell-based tissue engineering of murine teeth", J Dent Res, 83, pp.518~522 (2004)
- Rafii S, "Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration", Nat Med, 9, pp.702~712 (2003)
- Sawa Y, "Vascular endothelium of human dental pulp expresses diverse adhesion molecules for leukocyte emigration", Tissue Cell, 30, pp.281~291 (1998)
- Schatteman GC, "Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and HEPCs", Curr Top Dev Biol, 64, pp.141~180 (2004)
- Schatteman GC, "Hemangioblasts, angioblasts, and adult endothelial cell progenitors", Anat Rec A Discov Mol Cell Evol Biol, 276, pp.13~21 (2004)
- Stamm C, "Autologous bone-marrow stem-cell transplantation for myocardial regeneration", Lancet, 361, pp.45~46 (2003)
- Takahashi T, "Ischemia- and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization", Nat Med, 5, pp.434~438 (1999)
- Taniguchi E, "Endothelial progenitor cell transplantation improves the survival following liver injury in mice", Gastroenterology, 130, pp.521~531 (2006)
- Trubiani O, "Human dental pulp vasculogenesis evaluated by CD34 antigen expression and morphological arrangement", J Dent Res, 82, pp.742~747 (2003)
- Vokes SA, "Hedgehog signaling is essential for endothelial tube formation during vasculogenesis", Development, 131, pp.4371~4380 (2004)
- Wilting J, "Embryonic angiogenesis: a review", Naturwissenschaften, 83, pp.153~164 (1996)
- Xie RF, "Effect of cyclophosphamide on the bone marrow hematopoiesis in the mouse", Zhonghua Zhong Liu Za Zhi, 7, pp.435~437 (1985)